Business Context and Reporting Period
Aveanna Healthcare Holdings Inc. filed this Form 8-K on March 14, 2024, under Items 2.02, 7.01, and 9.01. The company announced financial results for the three-month period and fiscal year ended December 30, 2023. The filing concerns Aveanna’s common stock, traded on Nasdaq under the symbol AVAH.
Financial Results and Key Metrics
The filing references a press release furnished as Exhibit 99.1, but the provided filing text does not include the press release’s financial data. Revenue, profit or loss, cash flow, margins, debt, liquidity, and other key metrics are therefore not clearly available in the supplied text.
Material Changes Versus the Prior Comparable Period
The filing text does not provide comparative financial figures or describe material year-over-year or quarter-over-quarter changes.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook commentary, risk updates, contingencies, or unusual-item disclosures. These matters may be addressed in Exhibit 99.1, which is referenced but not included in the supplied content.
The information in Items 2.02 and 7.01, including Exhibit 99.1, was furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless specifically incorporated.
Important Facts to Verify
- Obtain and review Exhibit 99.1 for the complete fourth-quarter and fiscal-year 2023 financial results.
- Verify revenue, operating income, net income or loss, adjusted measures, cash flow, debt, and liquidity figures.
- Review management’s outlook, guidance, explanations of material changes, and any identified risks or unusual items.
- Confirm the reporting period ended December 30, 2023 and the March 14, 2024 release date.
- Note that this Form 8-K furnishes the referenced information rather than filing it for Exchange Act Section 18 liability purposes.